Company performance
Add to research
Current Price
as of Apr 25, 2025$7.42
P/E Ratio
N/A
Market Cap
$691.29M
Description
Add to research
Myriad Genetics, Inc. engages in the discovery, development, and marketing of transformative molecular diagnostic tests. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.
Metrics
Add to research
Overview
- HQSalt Lake City, UT
- SectorHealth Technology
- IndustryMedical Specialties
- TickerMYGN
- Price$7.42+0.68%
Trading Information
- Market cap$691.29M
- Float95.63%
- Average Daily Volume (1m)1,454,704
- Average Daily Volume (3m)1,227,659
- EPS-$1.41
Company
- Revenue$837.60M
- Rev growth (1yr)11.21%
- Net income-$127.30M
- Gross margin69.89%
- EBITDA margin-3.10%
- EBITDA-$26.00M
- EV$1.27B
- EV/Revenue1.52
- P/EN/A
- P/S0.81
- P/B0.98
- Debt/Equity20.01
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account